Orbicular Pharmaceutical Technologies
Develops niche and complex pharmaceutical dosage forms for licensing to its global partners.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $20.0m | Growth Equity VC | |
| Total Funding | 000k | ||
Related Content
Orbicular Pharmaceutical Technologies Pvt. Ltd. specializes in developing niche generic and specialty pharmaceutical products. The company focuses on late-stage licensing to global partners, ensuring that products meet stringent regulatory requirements worldwide. Orbicular serves pharmaceutical companies looking for high-quality, innovative solutions in complex injectables, topicals, ophthalmics, parenterals, sprays, inhalations, microspheres, nano suspensions, nano emulsions, liposomes, high-end peptides, and depot suspension injections. The business operates in the pharmaceutical industry, leveraging a partnership-led model to deliver outcomes-based solutions. Revenue is generated through licensing agreements and outsourcing partnerships. Orbicular's state-of-the-art facility in Hyderabad is equipped with sophisticated analytical tools and a dedicated scientific team, ensuring quality and efficiency in research and development. The company's commitment to quality is underscored by its ISO 9001:2008 certification and a Quality by Design approach, which integrates quality into every phase of the product lifecycle.
Keywords: niche generics, specialty pharmaceuticals, late-stage licensing, global regulatory, complex injectables, nano suspensions, liposomes, depot injections, partnership model, Hyderabad facility.